Ianthellamide A, a selective kynurenine-3-hydroxylase inhibitor from the Australian marine sponge Ianthella quadrangulata

Bioorg Med Chem Lett. 2012 May 15;22(10):3398-401. doi: 10.1016/j.bmcl.2012.04.002. Epub 2012 Apr 7.

Abstract

Ianthellamide A (1), a novel octopamine derivative, was isolated from the Australian marine sponge Ianthella quadrangulata. Compound 1 selectively inhibited the activity of kynurenine 3-hydroxylase with an IC(50) value of 1.5 μM. It also significantly increased the level of endogenous kynurenic acid in rat brain and hence has the potential as a neuroprotective agent in the treatment of neurodegenerative disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzenesulfonates / pharmacology*
  • Enzyme Inhibitors / pharmacology*
  • Inhibitory Concentration 50
  • Kynurenine 3-Monooxygenase / antagonists & inhibitors*
  • Magnetic Resonance Spectroscopy
  • Marine Biology
  • Octopamine / analogs & derivatives*
  • Octopamine / pharmacology
  • Porifera / chemistry*

Substances

  • Benzenesulfonates
  • Enzyme Inhibitors
  • lanthellamide A
  • Octopamine
  • Kynurenine 3-Monooxygenase